Bristol-Myers Squibbb击败了收入估算,提高了股息,投资者兴趣混杂。 Bristol-Myers Squibb beat earnings estimates, raised its dividend, and saw mixed investor interest.

Bristol-Myers Squibb (BMY)报告收入为每股1.67美元,殴打估计数为0.20美元。 Bristol-Myers Squibb (BMY) reported earnings of $1.67 per share, beating estimates by $0.20. 该公司宣布季度股息为每股0.62美元。 The company announced a quarterly dividend of $0.62 per share. 尽管Groupama资产管理公司和Franklin Resources Inc(富兰克林资源公司)减少了其持有量,但其他公司,如对称资本LP公司和惠灵顿管理集团LLP公司增加了投资。 Despite Groupama Asset Management and Franklin Resources Inc. reducing their holdings, other firms like Diametric Capital LP and Wellington Management Group LLP have increased their investments. Bristol-Myers Squibb提供各种生物制药产品,市场上限为1 211.3亿美元。 Bristol-Myers Squibb offers various biopharmaceutical products and has a market cap of $121.13 billion.